BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8081971)

  • 1. WT1, a Wilms' tumour gene.
    Bard JB; Armstrong JF; Bickmore WA
    Exp Nephrol; 1993; 1(4):218-23. PubMed ID: 8081971
    [No Abstract]   [Full Text] [Related]  

  • 2. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
    Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
    Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
    Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour.
    Pelletier J; Bruening W; Li FP; Haber DA; Glaser T; Housman DE
    Nature; 1991 Oct; 353(6343):431-4. PubMed ID: 1654525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical presentation of Denys-Drash syndrome in a female with a novel Wt1 gene mutation.
    Machin GA
    Birth Defects Orig Artic Ser; 1996; 30(1):269-86. PubMed ID: 9125334
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of native WT1 protein from frozen human kidney and Wilms' tumors.
    Iben S; Royer-Pokora B
    Oncogene; 1999 Apr; 18(15):2533-6. PubMed ID: 10229205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells.
    Menke AL; Riteco N; van Ham RC; de Bruyne C; Rauscher FJ; van der Eb AJ; Jochemsen AG
    Oncogene; 1996 Feb; 12(3):537-46. PubMed ID: 8637710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA polymerase chain reaction detects different levels of four alternatively spliced WT1 transcripts in Wilms' tumors.
    Brenner B; Wildhardt G; Schneider S; Royer-Pokora B
    Oncogene; 1992 Jul; 7(7):1431-3. PubMed ID: 1320246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
    Park S; Tomlinson G; Nisen P; Haber DA
    Cancer Res; 1993 Oct; 53(20):4757-60. PubMed ID: 8402654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
    Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
    Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentially spliced exon 5 of the Wilms' tumor gene WT1 modifies gene function.
    Hewitt SM; Saunders GF
    Anticancer Res; 1996; 16(2):621-6. PubMed ID: 8687106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wilms' tumour: connecting tumorigenesis and organ development in the kidney.
    Rivera MN; Haber DA
    Nat Rev Cancer; 2005 Sep; 5(9):699-712. PubMed ID: 16110318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype/phenotype correlations in Wilms' tumor.
    Huff V
    Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial Wilms' tumor associated with a WT1 zinc finger mutation.
    Kaplinsky C; Ghahremani M; Frishberg Y; Rechavi G; Pelletier J
    Genomics; 1996 Dec; 38(3):451-3. PubMed ID: 8975729
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of Wilms' tumor genes.
    Hirose M
    J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A point mutation within exon 5 of the WT1 gene of a sporadic unilateral Wilms' tumor alters gene function.
    Guan LS; Liu JJ; Xu YH; Wang ZY
    Cancer Res; 1998 Sep; 58(18):4180-4. PubMed ID: 9751632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular genetics of Wilms' tumor].
    Papezová M; Mares J; Goetz P
    Cas Lek Cesk; 2001 Jun; 140(11):323-7. PubMed ID: 11431850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence of the WT1 upstream region including the Wit-1 gene.
    Gessler M; Bruns GA
    Genomics; 1993 Aug; 17(2):499-501. PubMed ID: 8406502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WT1 mutations associated with incomplete Denys-Drash syndrome define a domain predicted to behave in a dominant-negative fashion.
    Bardeesy N; Zabel B; Schmitt K; Pelletier J
    Genomics; 1994 Jun; 21(3):663-4. PubMed ID: 7959750
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin-like growth factor II and WT1 transcript localization in human fetal kidney and Wilms' tumor.
    Yun K; Fidler AE; Eccles MR; Reeve AE
    Cancer Res; 1993 Nov; 53(21):5166-71. PubMed ID: 8221652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.